Pacific Biosciences Of California (PACB) Change in Inventory (2011 - 2026)

Pacific Biosciences Of California's Change in Inventory history runs 16 years deep, the most recent figure standing at $3.2 million for Q1 2026.

• On a quarterly basis, Change in Inventory rose 26.32% year-over-year to $3.2 million in Q1 2026; TTM through Mar 2026 was $2.1 million, a 361.86% increase from a year earlier, with the FY2025 full-year figure at $1.4 million, down 82.94% from the prior year.
• Change in Inventory climbed to $3.2 million in Q1 2026 per PACB's latest filing, from -$3.5 million in the prior quarter.
• Across five years, Change in Inventory topped out at $13.3 million in Q1 2023 and bottomed at -$9.0 million in Q4 2023.
• The 5-year median for Change in Inventory is $3.2 million (2026), against an average of $3.6 million.
• Across the five-year window, Change in Inventory soared 235.25% in 2022 and plunged 185.47% in 2023, its largest moves.
• Year by year, Change in Inventory stood at $10.5 million in 2022, then plunged by 185.47% to -$9.0 million in 2023, then increased by 21.47% to -$7.1 million in 2024, then surged by 50.42% to -$3.5 million in 2025, then jumped by 191.42% to $3.2 million in 2026.
• Per Business Quant, the three latest PACB Change in Inventory figures stand at $3.2 million (Q1 2026), -$3.5 million (Q4 2025), and $1.1 million (Q3 2025).